NASPA Signs On to Letter Regarding Test and Treat

NASPA, along with 13 other national pharmacy organizations, has signed on to a letter to the Biden Administration regarding President Biden’s recent statements regarding test and treat, urging them to remove barriers preventing pharmacists from ordering oral antivirals and expand patient access to the “Test to Treat” initiative.

“Despite your statement during the State of the Union, Americans who test positive at a pharmacy will only be able to access time-sensitive oral antivirals, on the spot, from a limited number of pharmacies with in-house access to non-pharmacist prescribers, primarily in metropolitan areas,” the groups noted.

Read the Full Statement